Cerebrovascular Pathology Research Group, Department of Neurology, Girona Biomedical Research Institute (IdIBGi), Dr. Josep Trueta University Hospital, Girona, Spain; Cellular and Molecular Neurobiology Research Group, Department of Biology, University of Girona (UdG), Girona, Spain.
Cerebrovascular Pathology Research Group, Department of Neurology, Girona Biomedical Research Institute (IdIBGi), Dr. Josep Trueta University Hospital, Girona, Spain; Cellular and Molecular Neurobiology Research Group, Department of Biology, University of Girona (UdG), Girona, Spain.
J Proteomics. 2018 Jul 30;184:10-15. doi: 10.1016/j.jprot.2018.06.011. Epub 2018 Jun 18.
Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the only pharmacological approved treatment for ischemic stroke, despite its associated increasing risk of hemorrhagic transformation. Since many of rt-PA effects in blood-brain barrier (BBB) are not well characterized, the study of protein changes in BBB cells after rt-PA administration may help to understand its adverse effects. Our aim was to analyze protein levels of four commonly used housekeeping proteins: β-Actin, α-Tubulin, GAPDH and HPRT in bEnd.3 endothelial cell line subjected to oxygen and glucose deprivation (OGD) conditions and rt-PA treatment to determine their reliability as Western blot loading controls. bEnd.3 monolayers were subjected to 2.5 h of OGD and reperfusion with/without 20 μg/ml of rt-PA. At 3, 6, 24 and 72 h post-OGD, protein levels were analyzed by Western blot using Stain-Free technology. OGD significantly decreased β-Actin, α-Tubulin, GAPDH and HPRT protein levels at 3, 6, 24 and 72 h post-OGD without significant rt-PA treatment effects except for the GAPDH levels increase in control condition at 3 h post-OGD. The present study clearly demonstrated that β-Actin, α-Tubulin, GAPDH and HPRT proteins are not suitable as loading controls for Western Blot analysis in bEnd.3 cells after OGD.
We reported altered levels of β-Actin, α-Tubulin, GAPDH and HPRT housekeeping proteins in bEnd.3 endothelial cell line after an ischemic insult. Therefore, we demonstrated that these proteins are not suitable as loading controls for Western Blot analysis in our experimental conditions and we recommended the use of Stain-Free gels as an alternative to traditional housekeeping proteins normalization.
用重组组织型纤溶酶原激活剂(rt-PA)进行溶栓是治疗缺血性脑卒中唯一批准的药物治疗方法,尽管其相关的出血性转化风险增加。由于 rt-PA 在血脑屏障(BBB)中的许多作用尚未得到很好的描述,因此研究 rt-PA 给药后 BBB 细胞中的蛋白质变化可能有助于了解其不良反应。我们的目的是分析四种常用管家蛋白(β-肌动蛋白、α-微管蛋白、GAPDH 和 HPRT)在 bEnd.3 内皮细胞系中经历氧葡萄糖剥夺(OGD)条件和 rt-PA 治疗后的蛋白质水平,以确定它们作为 Western blot 加载对照的可靠性。bEnd.3 单层在 2.5 小时的 OGD 和再灌注下进行,有/没有 20μg/ml 的 rt-PA。在 OGD 后 3、6、24 和 72 小时,使用 Stain-Free 技术通过 Western blot 分析蛋白质水平。OGD 显著降低了β-肌动蛋白、α-微管蛋白、GAPDH 和 HPRT 蛋白水平在 OGD 后 3、6、24 和 72 小时,除了在 OGD 后 3 小时对照条件下 GAPDH 水平增加外,没有显著的 rt-PA 治疗作用。本研究清楚地表明,β-肌动蛋白、α-微管蛋白、GAPDH 和 HPRT 蛋白不适合作为 bEnd.3 细胞 OGD 后 Western blot 分析的加载对照。
我们报道了缺血性损伤后 bEnd.3 内皮细胞系中β-肌动蛋白、α-微管蛋白、GAPDH 和 HPRT 管家蛋白水平的改变。因此,我们证明了在我们的实验条件下,这些蛋白质不适合作为 Western blot 分析的加载对照,我们建议使用 Stain-Free 凝胶作为传统管家蛋白归一化的替代方法。